FDA ANDA · ANDA091341

TRAVOPROST

Sponsor: PAR PHARM

APPLICATION

ANDA091341

TYPE

ANDA

ROUTE

OPHTHALMIC

DOSAGE FORM

SOLUTION

MARKETING STATUS

None (Tentative Approval)

Products

TRAVOPROSTNone (Tentative Approval)

TRAVOPROST 0.004% · SOLUTION · OPHTHALMIC

2011-08-19OriginalTA

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.